SYNENDOS THERAPEUTICS

synendos-therapeutics-logo

Synendos Therapeutics develops a class of small molecules for the treatment of anxiety and stress-related disorders. The company also develops breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of the natural functioning of the brain. The inhibitors act with a new mechanism of action that enables restoration of the natural function of the brain by rebalancing altered neurotransmission in different areas of the bran. There is a high demand for new pharmacological treatments in this area especially for certain diseases such as post-traumatic stress disorder (PTSD) which has a high unmet medical need.

#People #Financial #Event #Website #More

SYNENDOS THERAPEUTICS

Social Links:

Industry:
Health Care Medical Therapeutics

Founded:
2019-04-01

Address:
Allschwil, Basel-Landschaft, Switzerland

Country:
Switzerland

Website Url:
http://www.synendos.com

Total Employee:
1+

Status:
Active

Total Funding:
44.26 M CHF

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business GStatic Google Static Content Sectigo SSL Sectigo Domain SSL Lorem Ipsum



Current Advisors List

soren-lemonius_image

Soren Lemonius Board Member @ Synendos Therapeutics
Board_member
2020-11-12

not_available_image

Jutta Heim Chair of Advisory Board @ Synendos Therapeutics
Advisor

peter-neubeck_image

Peter Neubeck Board Member @ Synendos Therapeutics
Board_member
2020-11-12

Current Employees Featured

simon-russell_image

Simon Russell
Simon Russell Co-Founder @ Synendos Therapeutics
Co-Founder

andrea-chicca_image

Andrea Chicca
Andrea Chicca Co-Founder, Chief Executive Officer and Chief Scientific Officer @ Synendos Therapeutics
Co-Founder, Chief Executive Officer and Chief Scientific Officer
2019-04-01

jurg-gertsch_image

Jurg Gertsch
Jurg Gertsch Co-Founder and Head of Scientific Advisory Board @ Synendos Therapeutics
Co-Founder and Head of Scientific Advisory Board

Founder


andrea-chicca_image

Andrea Chicca

jurg-gertsch_image

Jurg Gertsch

simon-russell_image

Simon Russell

Investors List

ysios-capital_image

Ysios Capital

Ysios Capital investment in Series A - Synendos Therapeutics

lichtsteiner-foundation_image

Lichtsteiner Foundation

Lichtsteiner Foundation investment in Series A - Synendos Therapeutics

zรผrcher-kantonalbank_image

Zรผrcher Kantonal Bank

Zรผrcher Kantonal Bank investment in Series A - Synendos Therapeutics

high-tech-grรผnderfonds_image

High-Tech Grunderfonds

High-Tech Grunderfonds investment in Series A - Synendos Therapeutics

kurma-life-science-partners_image

Kurma Partners

Kurma Partners investment in Series A - Synendos Therapeutics

essential-investment-partners_image

Essential Investment Partners

Essential Investment Partners investment in Series A - Synendos Therapeutics

bernina-bioinvest_image

Bernina BioInvest

Bernina BioInvest investment in Series A - Synendos Therapeutics

schroder-adveq_image

Schroder Adveq

Schroder Adveq investment in Series A - Synendos Therapeutics

sunstone-capital-life-science_image

Sunstone Life Science Ventures

Sunstone Life Science Ventures investment in Series A - Synendos Therapeutics

venturekick_image

Venture Kick

Venture Kick investment in Pre Seed Round - Synendos Therapeutics

Newest Events participated

pitch-night-2019-the-future-of-healthtech_event_image Participated in Pitch Night 2019: The Future of HealthTech on 2019-06-12 as exhibitor

Official Site Inspections

http://www.synendos.com Semrush global rank: 4.12 M Semrush visits lastest month: 2.92 K

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.171
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "Synendos Therapeutics" on Search Engine